Endothelin-1 is involved in stretch-induced early activation of B-type natriuretic peptide gene expression in atrial but not in ventricular myocytes: acute effects of mixed ET(A)/ET(B) and AT1 receptor antagonists in vivo and in vitro

Circulation. 1997 Nov 4;96(9):3053-62. doi: 10.1161/01.cir.96.9.3053.

Abstract

Background: The precise role of paracrine and autocrine factors in mechanical load-induced activation of cardiac gene expression is unknown. Here we report the effects of endothelin-1 (ET-1) and angiotensin II (Ang II) receptor antagonism on acute pressure overload-induced activation of cardiac B-type natriuretic peptide (BNP) gene expression in spontaneously hypertensive rats (SHRs) in vivo and on mechanical stretch-induced increase in atrial BNP gene expression in vitro.

Methods and results: Acute pressure overload produced in conscious SHRs by infusion of arginine8-vasopressin (0.05 microg x kg(-1) x min(-1)) for 2 hours resulted in an increase in BNP mRNA levels in the left ventricle as well as in the atrium. Bolus injections of bosentan (mixed ET(A)/ET(B) receptor antagonist, 10 mg/kg I.V.) but not losartan (AT1 receptor antagonist, 10 mg/kg I.V.) blocked the increase of the BNP mRNA levels produced by pressure overload in the left atria, whereas the elevation of BNP mRNA levels was similar (a 1.9-fold increase) in the left ventricles of vehicle-, losartan-, and bosentan-infused SHRs. In an isolated perfused rat heart preparation, infusion of bosentan (1 micromol/L) for 2 hours inhibited the mechanical stretch-induced increase in BNP mRNA levels in the right atria, whereas an AT1 receptor antagonist, CV-11974 (10 nmol/L), had no effect.

Conclusions: The findings of the present study demonstrate that Ang II and ET-1 are not obligatorily required for stretch to trigger the increased BNP gene expression in ventricular myocytes in vivo. In contrast, mechanical load on the atrial myocytes did initiate an ET-1-dependent expression of BNP gene showing that endogenous ET-1 production differentially regulates BNP gene expression in atrial and ventricular myocytes.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Angiotensin Receptor Antagonists*
  • Animals
  • Benzimidazoles / pharmacology
  • Biphenyl Compounds
  • Bosentan
  • Endothelin Receptor Antagonists*
  • Endothelin-1 / physiology*
  • Gene Expression Regulation*
  • Losartan / pharmacology
  • Male
  • Myocardium / metabolism*
  • Natriuretic Peptide, Brain
  • Nerve Tissue Proteins / genetics*
  • Perfusion
  • RNA, Messenger / analysis
  • Rats
  • Rats, Inbred SHR
  • Rats, Sprague-Dawley
  • Receptor, Endothelin A
  • Receptor, Endothelin B
  • Sulfonamides / pharmacology
  • Tetrazoles / pharmacology

Substances

  • Angiotensin Receptor Antagonists
  • Benzimidazoles
  • Biphenyl Compounds
  • Endothelin Receptor Antagonists
  • Endothelin-1
  • Nerve Tissue Proteins
  • RNA, Messenger
  • Receptor, Endothelin A
  • Receptor, Endothelin B
  • Sulfonamides
  • Tetrazoles
  • Natriuretic Peptide, Brain
  • Losartan
  • Bosentan
  • candesartan